Tissue repair models are essential to explore the pathogenesis of wound healing and scar formation, identify new drug targets/biomarkers and to test new therapeutics. However, no animal model is an exact replicate of the clinical situation in man as in addition to differences in the healing of animal skin; the response to novel therapeutics can be variable when compared to human skin. The aim of this review is to evaluate currently available non-animal wound repair models in human skin, including: in silico, in vitro, ex vivo, and in vivo. The appropriate use of these models is extremely relevant to wound-healing research as it enables improved understanding of the basic mechanisms present in the wound healing cascade and aid in discovering better means to regulate them for enhanced healing or prevention of abnormal scarring. The advantage of in silico models is that they can be used as a first in virtue screening tool to predict the effect of a drug/stimulus on cells/tissues and help plan experimental research/clinical trial studies but remain theoretical until validated. In vitro models allow direct quantitative examination of an effect on specific cell types alone without incorporating other tissue-matrix components, which limits their utility. Ex vivo models enable immediate and short-term evaluation of a particular effect on cells and its surrounding tissue components compared with in vivo models that provide direct analysis of a stimulus in the living human subject before/during/after exposure to a stimulus. Despite clear advantages, there remains a lack of standardisation in design, evaluation and follow-up, for acute/chronic wounds and scars in all models. In conclusion, ideal models of wound healing research are desirable and should mimic not only the structure but also the cellular and molecular interactions, of wound types in human skin. Future models may also include organ/skin-on-a-chip with potential application in wound healing research.
ABSTRACT
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Many types of models exist that help to investigate the processes involved in normal cutaneous wound healing to optimise the ultimate results of tissue repair. 1 These models are also essential to explore the pathogenesis of chronic wounds and abnormal scar formation, identify new drug targets and to test new therapeutics. 2 One factor in choosing the ideal model is to determine which type of wound and phase of healing is to be investigated. 3 Thus, tissue repair models can be evaluated with respect to the following distinct stages of wound healing: wound granulation tissue formation, contraction, re-epithelialisation, and scar remodeling. 3 Animal models, in vitro cell culture and tissueengineered models have been used with varying degrees of success to represent human skin. 1 However, animal models are not perfect as they do not always accurately represent the structure of human skin or develop similar scars, which are comparable to abnormal scars observed in humans such as keloid scars. 4, 5 In addition, the potential cost, ethical, and moral issues associated with their use can be challenging and problematic. [6] [7] [8] The best current animal model in terms of dermal structure and underlying mechanisms is considered to be the pig. [9] [10] [11] Nevertheless, no animal model is shown to be an exact replicate of the clinical wound healing scenario seen in man.
Numerous models have been developed to study wound repair in humans which aim to identify key underlying mechanisms and better understanding of the process of healing. These include in silico, in vitro, ex vivo, and in vivo models (Figure 1) . In silico models can be useful but lack the biophysical characteristics of human skin. 7 In vitro models provide valuable information about one or few components of the skin at a time, but do not correlate with their in vivo counterparts due to their lack of complexity. 6, 12 Additionally, ex vivo models enable immediate and short-term evaluation of a particular effect on cells as well as its surrounding tissue components although there is a lack of standardisation and comparable emulation of the in vivo environment in toto. 11 Furthermore, patient and volunteer studies remain essential and pivotal to testing of emerging novel therapeutics but the appropriate methodology should be chosen for the type of wound or scar being studied. 6 In view of this, the aim of this review is to evaluate currently available models of wound repair in human skin and offer a detailed overview of their clinical and scientific relevance and utility.
MATERIALS AND METHODS
The available literature was reviewed regarding nonanimal models of wound repair. The PubMed and Scopus databases were used to search the recent literature to 2016. Different combinations of terms were used, including models, wound repair, wound healing, tissue repair, in vivo, ex vivo, in vitro, in silico, experimental, human. Articles not written in English and those that did not include relevant information were excluded. Relevant articles referenced within the articles identified with the above search were also included. All retrieved articles were reviewed for their relevance to the specific topic.
RESULTS
The results will now be presented under the headings in silico, in vitro, ex vivo, and in vivo models.
In silico models
The complexity of the biochemical and biophysical processes involved in tissue regeneration highlight the need for computational models to understand cell growth and to design efficient scaffolds and tissue substitutes. 13 Multiphase models have been used to describe time-dependent processes in vitro in a perfusion bioreactor, with particular focus on cell growth, access to nutrients, and scaffold degradation.
14 Other computational methods have modeled cell spreading and tissue regeneration in vitro using porous scaffolds. They looked at transport and nutrient intake, cell population, ECM deposition, cell attachment, and migration. 13, 15, 16 Agent-based models have been used to investigate the role of growth factors, 17 organisation of keratinocytes, 18 presence of fibroblasts, 19 and the importance of stem cells in long-term skin epithelium regeneration. 20 In silico models may be useful theoretically and in combination with other models but are lacking the physical characteristics of human skin. 6 A number of models have been designed using differential equations. [21] [22] [23] [24] These models have been developed to analyse strategies for improved healing, such as wound negative pressure therapy devices, commercially engineered skin substitutes, and hyperbaric oxygen therapy. Mathematical models using ordinary differential equations have been developed to investigate the effects of commercially engineered skin substitutes. Waugh and Sherratt suggest that the model can be used to explore the effects on interpatient variability or the gradual release of treatment components. 22 Models using partial differential equations have also been designed to analyse the effects of hyperbaric oxygen on the promotion of wound angiogenesis. 23, 24 Both models used the "snail-trail" model of angiogenesis. 25 A mechanical model using a finite-element method has also been used to analyse negative pressure therapy and the simulation results are consistent with the in vitro strain levels shown to promote cell proliferation. 26 This approach may be used to evaluate treatment strategies that promote cell proliferation, growth-factor production, and wound angiogenesis by applying micromechanical forces.
Computational approaches for deterministic systems in wound healing have been tested. There have been analyses of changes in wound morphology using either planar or axisymmetric wounds. 27 A two-dimensional epidermal wound was used to assess the wound boundary using a level-set method. Additionally, a further study used a similar method analysing wound contraction using the finite-element method. 28 Agent-based models have been developed to analyse different treatment strategies with wound debridement and topical administration of growth factor. 21 Many studies have used agent-based models for a multiscale approach to wound healing. 18, 19, 29, 30 A multiscale approach has also been developed for deterministic systems using a hybrid continuous-discrete model when studying the flow through a vascular network. 31, 32 Recently, a continuum hypothesis-based model enabled simulation of the formation and regression of hypertrophic scar tissue after dermal wounding. 33 
In vitro models
There are several in vitro models of tissue repair that can assist with responding to specific mechanistic questions related to wound repair. 12, 34 Many of these in vitro models are used to answer basic questions related to cell signaling in response to cell stress or injury. 34 In vitro cell culture models have been used for many years to gain insight into different aspects of scar pathogenesis. 12, 34 In vitro models can be categorised as single cell, co-culture and organotypic ( Figure 2 , Supporting Information Figure S1 ). Single cell models work by the relevant cells being grown in vitro after which a "wound" is made in the cell layer by scraping the dish surface with either rubber devices or the tip of a pipette, thus, removing cells from the scraped area, creating a scratch and trauma to the cells next to the wound. 34 Subsequently, the rate at which cells divide and migrate into the "wound" area is determined microscopically.
34 The basic physiological processes are then analysed including proliferation, protein production and secretion, viability, migration, gene expression and differentiation. 35 Single cell models are often used with dermal fibroblasts and keratinocytes [36] [37] [38] testing various agents for the enhancement of fibroblast migration or reepithelialisation.
To overcome the limitations of single cell models, several three-dimensional in vitro models have been utilised. 39, 40 Fibroblasts are seeded in a type I collagen solution which is solidified to gel, resulting in cells being embedded in a three-dimensional collagen lattice that is then transferred to a culture dish and covered with medium. 41 This model enables the evaluation of cell contraction and matrix compaction. Another wound healing model 42 embedded fibroblasts in a 3D collagen construct and the cell migration is followed from the denser collagen matrix into a surrounding matrix. The limitations of this model include the use of only one type of ECM protein and one cell type.
A number of recent quantitative studies have analysed in vitro wounding assays to investigate aspects of cell migration for various cell types. [43] [44] [45] [46] [47] Human in vitro models were used in a study to investigate human skin integrity, wound closure, and scar formation. 48 These methods included, cell culture, fibroblast and endothelial cell migration scratch assay, fibroblast chemotaxis assay, endothelial cell in vitro tube formation assay, and skin equivalent. The authors showed that these models provided a platform for testing the mode of action of novel compounds for enhanced and scar free wound healing. Two dimensional cell culture models do not represent the interactions and mechanisms present in whole skin, such as the effect of the extracellular matrix (ECM) in terms of structure, as well as cell signaling mechanisms and the processes of metabolism. 49 Indirect co-cultures of keratinocytes and fibroblast monolayers using transwell systems has also enabled the study of keratinocyte-fibroblast interactions. 50, 51 The transwell assay or Boyden chamber assay has been used to analyse the chemotactic responses of leukocytes. 52 The principle of this assay is based on two mediums containing chambers separated by a porous membrane. 51 The transwell migration assay can be used for many different cell types including epithelial, 53 mesenchymal, 54 and brain cancer cell lines 55 as well as many primary cells. However, it is difficult to obtain the 3D macroscopic fibrotic tissue structure of a scar. The expression of biomarkers from gene and protein studies is affected by the 3D structure of a scar. 34 The use of a more 3D environment such as collagen and mechanical load can positively influence the behaviour of fibroblasts by creating a more realistic condition. 56, 57 One study cultured human cells derived from patients with chronic venous ulcers using biopsies and demonstrated that they maintain their in vivo phenotype. 58 Fibroblasts derived from different wound locations were tested for their migration capacities and another portion of the patient biopsy was used to develop primary fibroblast cultures after rigorous passage. Another study also used chronic wounds for in vitro assessment by taking punch biopsies from patients with venous ulcers and evaluated their histology, biological response to wounding (migration), and gene expression profile. 59 Scratch assays are commonly used to observe the migration and proliferation of cells. [60] [61] [62] Cells are placed on a culture dish and incubated, eventually forming a monolayer. 63 An artificial wound is created and images of the cell spreading by migration and proliferation are captured over 12-24 hours. [64] [65] [66] Various cell types have been analysed for migration with this assay including epithelial and mesenchymal cancer cells, keratinocytes, normal epithelial cells, endothelial cells, and fibroblasts. [67] [68] [69] [70] [71] [72] The majority of scratch assays fall into one of two categories; wound assay or scrape assay. The wound assay involves the creation of a thin wound, 61, 63 which produces two opposing directed cell fronts which merge. 64 The scrape assay, involves a monolayer that has been scratched further so there is only one cell type. 64 Scratch assays have been used to investigate the influence of various chemical compounds and potential drug treatments on the rates of cell motility and proliferation. 60, 62 When keratinocytes are cultured separately and then placed on top of the collagen gel containing fibroblasts, an organotypic skin-like three-dimensional culture is created. 73 This model enables analysis of the interaction between these two types of cells in a three-dimensional manner. Organotypic skin equivalents have been used to investigate scar pathogenesis. 74 3D skin equivalent models have used keloid fibroblasts in combination with normal skin-derived keratinocytes. 50, 75 Using a similar method, a fully differentiated epidermis constructed from keratinocytes isolated from hypertrophic scars on a fibroblast populated dermal matrix showed characteristics of an abnormal scar including dermal thickness, epidermal thickness and collagen I and illustrated the role of keratinocytes in hypertrophic scar formation. 76 Use of these models for testing therapies is limited due to the lack of validated biomarkers and the dependence on excised scar tissue. Whilst in vitro models have many benefits, they also have some limitations. The majority of cell culture models employ serum to support and enhance the growth of cells in vitro. 44, 45 Serum is a pathologic, inflammatory fluid compared to plasma and interstitial fluid that normal, resting cells experience. Therefore, any observations made of cells in a serum environment should be made with caution when assuming normal cellular function and behaviour.
Ex vivo models
Ex vivo human skin tissue is more appropriate for certain types of research. The use of whole skin biopsies in culture allows the effect of individual ingredients and formulations to be tested in an environment more closely mimicking normal skin. 77 Full-thickness skin organ culture is already an established tool used for understanding human skin pathophysiology and evaluation of novel treatments. [78] [79] [80] [81] A number of wound healing organ culture models have been previously reported in studying cutaneous wound healing processes. 73, 82, 83 Therapies including anti-inflammatory interleukin 10, anti-fibrotic streptolysin O, and dermal substitutes have been evaluated using this model. 78, 79, 83 Despite promising results, there is a lack of standardisation and conformity in these studies. Variations in the methodologies include the use of different wound types such as a partial or full thickness wound, different culture conditions, and a range of support and growth mediums. 80, 84 Ex vivo model types can be divided into normal skin models and pathological skin models (Figures 3 and 4) .
A study looking at the effects of topical formulations on human skin demonstrated that altered expression of key gene and protein markers could be quantified in an optimised whole tissue biopsy culture model. 1 This model could be adapted to investigate a range of candidate compounds or disease mechanisms, negating the requirement for animal models, and certainly prior to initiating an in vivo clinical trial.
The ex vivo donut-shaped wound healing model has been used to investigate human cutaneous repair. 85, 86 In a study by Sebastian et al., human tissue was collected and wounded using a standardised punch biopsy (full thickness wound) and the effect of electrical stimulation was evaluated. 85 Another study also used this model for studying the effect of dermal substitutes on human dermal fibroblasts and keratinocytes. 86 Full thickness lower abdominal skin was collected and 8 mm punch biopsies taken from human patients. In the centre of these cylindrical skin biopsies, a 4 mm full thickness artificial wound was created by a further punch biopsy. Models were placed into 24-well plate inserts and prepared dermal substitutes were inserted into the wound area. This model has been shown to be useful in studying cutaneous wound healing.
Ex vivo models have been used when analysing stretch marks and scars including hypertrophic and keloid scars. [87] [88] [89] Multipotent keloid-derived mesenchymal-like stem cells, found in the scar, have been implicated in keloid formation. 88, 89 Therefore, keloid explant models are interesting as they allow these cells to remain in their location. Ex vivo biopsies have been cultured at air-liquid interface, embedded in collagen gels. 90, 91 The functionality of this model was confirmed by the reduced epidermal thickness and scar volume after treatment with the dexamethasone. A further study evaluated the effect of two promising candidate anti-fibrotic therapies: (-)-epigallocatechin-3-gallate and plasminogen activator inhibitor-1 (PAI-1) silencing in a long-term human keloid organ culture (OC). 92 This model has several advantages; the keloid explants remain viable in culture for up to 6 weeks without tissue deterioration, the maintenance of the keloid cellular and microenvironments enable examination of keloid pathophysiology in situ and anti-fibrotic agents and gene silencing using RNA interference technology can be used to investigate the cellular and molecular interactions in the epidermis and dermis. 91 The results showed that these therapies inhibited growth and induced shrinkage of human keloid tissue and found this to be an effective model. 92 Another study assessed the extent to which differences relating to cell type influence PAI-1 gene regulation with regard to growth state-associated mechanisms of expression control using keloid fibroblasts and normal dermal fibroblasts for cell culture. 93 A further ex vivo study utilised an organ culture model of dermal fibrosis to investigate the effect of photodynamic therapy on skin scars and stretch marks in humans. 87 This unique ex vivo model showed the morphological and cellular effect of photodynamic therapy and correlated this with the degree and severity of dermal fibrosis.
In vivo models
Human in vivo models are useful as the pathology and physiology of healing (in particular in acute wounds) is directly relevant to that found in the patient. There are a number of wound models that can be inflicted on a human patient or volunteer to provide accurate and representative research tools (Figures 5 and 6 ). Due to the difficulty in obtaining suitable volunteers with chronic wounds and incorporating them into a study, human acute wound models provide the best opportunity to understand the wound healing process and the performance of different products that aid and promote wound healing. Both patient and volunteer models have their advantages and limitations. Patient models allow assessment in a variety of wound or scar types, whilst volunteer models only enable evaluation of one type of wound/scar in a given period of time.
Patient model
Patient studies remain essential and are always necessary to validate potential novel wound and scar therapies identified in other wound and scar models. Patient models are useful as any wound type can be assessed using a variety of methods including incisions, excisions, and sequential punch biopsies (in non-keloid formers). However, chronic wound studies have limitations due to the heterogeneity of the population and lack of uniformity of the wound type.
Patients with scars can be used to explore the pathogenesis of scar formation, however, keloid formers are seldom included due to concerns for recurrence and worsening of existing scars unless provided with full and adjuvant therapy plus adequate follow-up. Incisional wound models are useful as they can be accurately reproduced and can be used for multiple investigations. This model can evaluate the wound healing process and the influence of different local compounds/dressings, response to energy-based therapies, as well as systemic effects of drugs. This model has been used extensively following cutaneous surgery to evaluate quantitative outcome measures including rate of wound closure, quality of healing as well as wound strength. 94, 95 Biomechanical analysis of soft tissue and incisional wounds in different types of tissues have also been described. 96 Acute wounds such as split-thickness donor sites have the benefit in that two wounds can be created in a controlled fashion in the same patient. In a randomised, blinded fashion, one wound can be treated with the therapy under investigation and the other can act as the control leading to an optimal study design. 97, 98 Volunteer models Human volunteer models enable assessment of a homogeneous population and the volunteers can act as their own controls. The limitations of these models are the inability to create other abnormal wound or pathological scar types such as chronic wounds or keloid scars. A number of volunteer models have been utilised including excisional, incisional, scratch, blister, tape stripping, and burns. Biopsy models have been used which enable a standardised approach as the subjects can act as their own controls. These wounds are useful from an experimental perspective in that their size and depth can be precisely controlled. As they involve all the components of the healing process, they provide an excellent research tool and have been used to investigate angiogenesis, wound contraction, and wound closure. 99 Numerous studies have been conducted evaluating various treatments for both wounds and scars using a sequential skin punch biopsy model to assess various characteristics and correlated by clinical measurements. [99] [100] [101] [102] [103] [104] Furthermore, studies have also monitored treatment efficacy in raised dermal scarring including hypertrophic and keloid scars using objective noninvasive measures. [105] [106] [107] However, difficulties arise when attempting to experimentally monitor the tissue in particular in keloid scars as sequential repeat biopsy would prove challenging and may lead to further abnormal scarring. For these in vivo studies, it is important to clarify the definition of healing in the human wound. The endpoint should be identified clearly (when the wound has healed), and the severity and stage of scar formation should be noted at the outset. The advantages of this biopsy model are that it uses a wound with loss of tissue as found in clinical practice. These wounds enable the evaluation of different therapies with the ability to create the same wounds each time and measure different healing parameters quantitatively. Early healing can be monitored followed by scarring and surrounding wound area can be observed. The disadvantage is that the wound heals from the edges as well as by contraction.
A study by Dunkin et al. investigated the association between scarring and depth of dermal injury. They developed a novel device, which produced a wound that was deep dermal at one end and superficial at the other to healthy volunteer hips. They showed that this dermal scratch model provided a standardized and reproducible model for investigating the healing response to dermal injury of different depths. 108 The blister model is used for the evaluation of epidermal regeneration and the influence of various therapies. Blisters are produced by suction using different types of devices which produce standardised, small, epidermal bulges. 109, 110 Normal human skin tends to blister after application of the device and a scalpel can then remove the blister roofs, therefore, creating identical superficial wounds of similar dimensions. 111 Absorption effect can also be evaluated under occlusive and semi-occlusive conditions and the transepidermal water loss can be measured for the skin barrier function. 112 The advantages of this model are that the wounds are identical and can be in the same anatomical location on the body. The disadvantages are that evaluation of such superficial wounds may have no relevance to much deeper dermal wound types.
The tape stripping model involved successive stripping of the epidermis using adhesive tape to disintegrate the skin barrier in the lowest part of the stratum corneum. 113 This can then be measured by a transepidermal water loss measurement device. 112 This model is less damaging to the epidermis than the blister model. A study used the tape stripping model to assess the penetration of quantum dots. 114 Adhesive tape was applied and pressed onto the skin using a roller. The skin was stripped with 15 pieces of adhesive tape. Negative control strips were obtained from a nontreated area of the upper arms. Tape strips removed from skin were analysed using confocal microscopy.
There have been studies that have created a burn in healthy volunteers to assess various therapies. A randomised double-blind cross-over study in six volunteers investigated the effects of intravenous lidocaine infusion on partial thickness skin burns. 115 A thermoprobe was used to induce a standardised thermal injury (1 cm 2 ) on the flexor side of one forearm and was repeated on the opposite side 1 week later. Another study directly compared UVB induced inflammation and the more established thermal burn and topical capsaicin pain models. 116 They delivered UVB to small areas of volar forearm skin in healthy volunteers and found that the degree of inflammation and concomitant increase in sensitivity to cutaneous stimuli were UVB dose and time dependent.
DISCUSSION
This review has evaluated currently available wound repair models in human skin, including: in silico, in vitro, ex vivo, and in vivo. The appropriate use of tissue repair models is extremely relevant to wound healing research as it enables improved understanding of the basic mechanisms involved in the wound healing cascade and aid in discovering better means for enhanced healing or prevention of abnormal scarring. 6 The advantage of in silico models is that they can be used as a first in virtue screening tool to predict the effect of a drug/stimulus on cells/tissues and help plan experimental research/clinical trial studies but remain theoretical until validated. 7 Additional limitations of the in silico mathematical model is the lack of standardisation which is highlighted by the arbitrary choice of specific healing parameter values use in these models. 7, 8 If the aim of the model is to provide a quantitative prediction of a physiological process, the model parameters require better quantification. 13 In vitro models allow direct quantitative examination of a particular effect on specific cell types alone without incorporating other tissue matrix components, which limits their utility. 12 Additionally, in vitro models have had a significant role in the study of wound healing and scar formation. 12, 34 This had led to a better understanding of biomarker expression, the role of keratinocytes and fibroblast activity in wound and scar development. [43] [44] [45] [46] [47] [48] Although the disadvantage is that, it can be difficult to extrapolate the findings of in vitro research to the in vivo wound scenario. Three dimensional models including extracellular matrix, human skin constructed from keloid-derived tissue, and mesenchymal cells, have been recently made to mimic the conditions in which these scars form. 88, 89 Ex vivo models enable immediate and short-term evaluation of a particular effect on cells and its surrounding tissue components compared with in vivo models that provide direct analysis in the live human subject before, during and after exposure to a stimulus. 12 Human in vivo models are useful as the pathology and physiology of healing is identical to that found in the patient. 99 Both patient and volunteer models have their advantages and limitations. Patient models allow assessment in a variety of wound or scar types, whilst volunteer models only enable evaluation of one type of wound or a similarly induced scar. 99, [105] [106] [107] Despite clear advantages, there remains a lack of standardisation and conformity in design, evaluation and follow-up, for all wound types including acute, chronic wounds, and scars.
Many of the human wound and scar models have a limited duration of days or weeks, whereas human scars develop over a period of months or years. 49, 50 Therefore, these models enable us to look at the early stages of wound healing and scar formation but may not accurately reflect the later stages of wound contraction or scar formation. Another limitation is that a number of cell types that are involved in the healing process have not yet been incorporated into the relevant human cell culture models. 117, 118 An emerging model is the organ-on-a-chip or skin-on-achip which involves engineered tissues, which are similar to the in vivo equivalents and consist of multiple different cell types interacting with each other under closely controlled conditions which are grown in a microfluidic chip. 108, 119, 120 These controlled conditions will make it possible to mimic the environment of the skin (humidity, temperature, pH, oxygen levels), the elasticity of the skin, and the complex structures and cellular interactions within and between the different cell types. 119 In summary, understanding the mechanism and pathophysiology of how scars form and wounds heal, is essential if we are to develop optimal strategies in the future to prevent delayed healing and abnormal scar formation. Ideal models of wound healing research should mimic not only the structure but also the cellular and molecular interactions, of wound types in the human skin.
